Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Unknown status Country / region: China Clear all

181 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20093
20105
20118
20128
20137
201410
20159
201613
201716
20183
201915
202017
202120
202223
202310
202410

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status181

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.14
Shanghai Jiao Tong University School of Medicine10
Peking Union Medical College Hospital6
Sun Yat-sen University6
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School6
Nanjing First Hospital, Nanjing Medical University5
Beijing Chao Yang Hospital4
Guang'anmen Hospital of China Academy of Chinese Medical Sciences4
Jiangsu Hansoh Pharmaceutical Co., Ltd.4
Zhongda Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2181
Diabetes Mellitus21
Obesity12
Insulin Resistance7
Diabetes Mellitus, Type 16
Cognitive Dysfunction4
Overweight4
Cardiovascular Diseases3
Diabetic Nephropathies3
Glucose Metabolism Disorders3

Trials

Showing 1 to 25 of 181. Each trial links to its page on Pharma Observatory.

81 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.